Oliger Christy J.

Reported to SECin USFilings at 3 companies

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Zenas BioPharma, Inc.—Awardnothing paid37,000 sharesSep 2, 2026Zenas BioPharma, Inc.nothing paidAward · Sep 2Award37,000Sep 2, 2026
Bicara Therapeutics Inc.—Awardnothing paid38,950 sharesJul 29, 2026Bicara Therapeutics Inc.nothing paidAward · Jul 29Award38,950Jul 29, 2026
Nuvalent, Inc.—Returned to the issuer—6,119 sharesJul 15, 2026Nuvalent, Inc.—Returned · Jul 15Returned to the issuer6,119Jul 15, 2026
Nuvalent, Inc.—Returned to the issuer—6,091 sharesJul 15, 2026Nuvalent, Inc.—Returned · Jul 15Returned to the issuer6,091Jul 15, 2026
Nuvalent, Inc.—Tender or change of control$164,1761,324 sharesJul 15, 2026Nuvalent, Inc.$164,176Tender · Jul 15Tender or change of control1,324Jul 15, 2026